샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787177

세계의 멘테루카스트나트륨 시장

Montelukast Sodium
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 278 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 멘테루카스트나트륨 시장은 2030년까지 11억 달러에 이를 전망

2024년에 5억 470만 달러로 추정되는 멘테루카스트나트륨 세계 시장은 2024-2030년간 CAGR 14.1%로 성장하여 2030년에는 11억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 정제 형태는 CAGR 12.5%를 나타내고, 분석 기간 종료시에는 6억 1,550만 달러에 이를 것으로 예측됩니다. 경구제 부문의 성장률은 분석 기간에 CAGR 16.5%로 추정됩니다.

미국 시장은 1억 3,750만 달러로 추정, 중국은 CAGR18.6%로 성장 예측

미국의 멘테루카스트나트륨 시장은 2024년에 1억 3,750만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR18.6%로 성장을 지속하여, 2030년까지 2억 3,580만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 10.6%와 12.5%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 11.2%를 나타낼 전망입니다.

세계 몬테루카스트 나트륨 시장 - 주요 동향 및 촉진요인 요약

몬테루카스트 나트륨이 호흡기 질환 치료에 널리 사용되는 이유는 무엇인가?

몬테루카스트 나트륨은 천식, 알레르기성 비염, 운동 유발성 기관지 수축 등 호흡기 질환의 치료제로 널리 처방되고 있습니다. 류코트리엔 수용체 길항제(LTRA)인 몬테루카스트는 기도 수축의 원인이 되는 염증 경로를 차단함으로써 작용하여 천식 관리에 효과적인 장기 치료제로 사용되고 있습니다. 공해, 기후 변화, 생활습관 변화로 인한 만성 호흡기 질환이 증가함에 따라 몬테루카스트 나트륨에 대한 수요가 전 세계적으로 급증하고 있습니다. 몬테루카스트는 코르티코스테로이드와 달리 경구투여가 가능하고 부작용이 적으며 소아에게도 사용할 수 있어 많은 환자들이 선호하고 있습니다. 또한, 계절성 알레르기 및 대기오염과 관련된 호흡기 질환 증가로 인해 처방약과 일반의약품 모두 몬테루카스트의 사용이 확대되고 있습니다.

몬테루카스트 나트륨 시장 잠재력을 높이는 의약품 제형의 발전은 무엇인가?

제약업계에서는 몬테루카스트 나트륨의 제형과 전달에 있어 큰 진전이 있었고, 생체이용률과 치료 효과가 향상되었습니다. 씹어먹을 수 있는 정제나 경구용 과립의 개발로 소아 및 노인 환자들이 치료 요법을 쉽게 준수할 수 있게 되었습니다. 또한, 몬테루카스트와 레보세티리진 등의 항히스타민제와의 병용요법은 알레르기 증상과 호흡기 증상 모두에 효과가 있어 인기를 얻고 있습니다. 또한, 환자의 순응도를 높이고 치료 효과를 지속시키기 위해 방출 조절 제제를 포함한 새로운 약물 전달 메커니즘도 연구되고 있습니다. 개인 맞춤형 의료로의 전환은 몬테루카스트의 반응에 영향을 미치는 유전적 요인에 대한 연구를 더욱 촉진하여 보다 표적화되고 효과적인 치료의 길을 열어주고 있습니다. 제약회사들이 혁신적인 제형에 대한 투자를 지속하는 가운데, 몬테루카스트 나트륨의 접근성과 사용 편의성이 향상될 것으로 기대됩니다.

호흡기 질환의 부담 증가는 시장 수요를 어떻게 형성하고 있는가?

천식, 만성폐쇄성폐질환(COPD), 알레르기성 질환의 전 세계 유병률 증가로 효과적인 호흡기 치료제에 대한 수요가 증가하면서 몬테루카스트 나트륨 시장을 견인하고 있습니다. 도시화와 산업화는 호흡기 질환의 주요 원인인 대기오염 증가로 이어지고 있습니다. 또한, 호흡기 질환에 취약한 노령인구 증가가 시장 확대에 기여하고 있습니다. 의료진은 천식 관리를 개선하기 위해 흡입용 코르티코스테로이드와 함께 몬테루카스트를 보조 요법으로 권장하고 있습니다. 코로나19 사태는 호흡기 건강에 대한 관심을 높이고 만성 호흡기 질환에 대한 인식과 진단율을 높이는 역할도 하고 있습니다. 또한, 흡입제보다 비침습적인 경구용 치료제를 선호하는 환자들의 선호도가 일부 지역에서 몬테루카스트 나트륨을 1차 선택 약물로 채택하는 데 영향을 미치고 있습니다.

몬테루카스트 나트륨 시장의 성장을 가속하는 주요 요인은?

몬테루카스트 나트륨 시장의 성장은 호흡기 질환의 유병률 증가, 의약품 혁신의 확대, 알레르기 질환에 대한 인식 증가 등 여러 요인에 의해 주도되고 있습니다. 비용 효율적이고 쉽게 구할 수 있는 천식 치료제에 대한 수요는 선진국과 신흥국 시장에서 몬테루카스트의 채택을 촉진하고 있습니다. 또한, 제네릭 의약품 제조업체의 확대는 시장 침투력을 높여 몬테루카스트를 보다 저렴한 가격으로 널리 이용할 수 있도록 했습니다. 또한, 몬테루카스트와 항히스타민제나 코르티코스테로이드제와의 병용요법이 증가하고 있는 것도 제약사들에게 새로운 비즈니스 기회를 제공합니다. 천식 관리 프로그램을 추진하려는 정부의 이니셔티브와 신흥국의 의료비 지출 증가는 시장 성장에 더욱 기여하고 있습니다. 개인 맞춤형 의료로의 전환과 더 나은 치료 결과를 얻기 위한 바이오마커 연구도 몬테루카스트 나트륨의 미래를 더욱 밝게할 것으로 예측됩니다. 전 세계적으로 호흡기 질환에 대한 부담이 지속적으로 증가함에 따라 몬테루카스트 나트륨 시장은 향후 몇 년 동안 지속적으로 확대될 것으로 예측됩니다.

부문

제형(정제, 경구제);용도(천식 용도, 알레르기성 비염 용도, 두드러기 용도, 기타 용도)

조사 대상 기업 예

  • Aarti Pharmalabs Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Hetero Drugs Limited
  • Inke S.A.
  • Intas Pharmaceuticals Ltd.
  • Jai Radhe Sales
  • Kimia Biosciences Ltd.
  • LGM Pharma
  • Merck & Co., Inc.
  • Metrochem API Private Limited
  • Minakem(formerly Delmar Chemicals)
  • Morepen Laboratories Ltd.
  • Neuland Laboratories Ltd.
  • Sanofi S.A.
  • Seqens
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.18

Global Montelukast Sodium Market to Reach US$1.1 Billion by 2030

The global market for Montelukast Sodium estimated at US$504.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2024-2030. Tablets Form, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$615.5 Million by the end of the analysis period. Growth in the Oral Solutions segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$137.5 Million While China is Forecast to Grow at 18.6% CAGR

The Montelukast Sodium market in the U.S. is estimated at US$137.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$235.8 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.6% and 12.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Global Montelukast Sodium Market - Key Trends & Drivers Summarized

Why Is Montelukast Sodium Gaining Widespread Adoption in Respiratory Disease Treatment?

Montelukast sodium has become a widely prescribed pharmaceutical for managing respiratory conditions such as asthma, allergic rhinitis, and exercise-induced bronchoconstriction. As a leukotriene receptor antagonist (LTRA), montelukast works by blocking inflammatory pathways that contribute to airway constriction, making it an effective long-term therapy for asthma management. With the increasing prevalence of chronic respiratory diseases due to pollution, climate change, and lifestyle factors, the demand for montelukast sodium has surged globally. Unlike corticosteroids, montelukast is preferred by many patients due to its oral administration, fewer side effects, and suitability for pediatric use. Additionally, the rise in seasonal allergies and air pollution-related respiratory issues has expanded the use of montelukast in both prescription and over-the-counter formulations.

What Advancements in Pharmaceutical Formulations Are Enhancing Montelukast Sodium's Market Potential?

The pharmaceutical industry has witnessed significant advancements in the formulation and delivery of montelukast sodium, improving its bioavailability and therapeutic efficacy. The development of chewable tablets and oral granules has made it easier for pediatric and geriatric patients to adhere to treatment regimens. Additionally, combination therapies incorporating montelukast with antihistamines, such as levocetirizine, have gained popularity for their dual-action benefits in managing both allergic and respiratory symptoms. Novel drug delivery mechanisms, including controlled-release formulations, are also being explored to improve patient compliance and prolong therapeutic effects. The shift toward personalized medicine has further driven research into genetic factors influencing montelukast response, paving the way for more targeted and effective treatments. As pharmaceutical companies continue to invest in innovative drug formulations, the accessibility and usability of montelukast sodium are expected to improve.

How Is the Rising Burden of Respiratory Diseases Shaping Market Demand?

The increasing global incidence of asthma, chronic obstructive pulmonary disease (COPD), and allergic conditions has created a substantial demand for effective respiratory therapies, boosting the montelukast sodium market. Urbanization and industrialization have led to rising levels of air pollution, a key trigger for respiratory conditions. Additionally, the growing geriatric population, which is more prone to respiratory diseases, has contributed to market expansion. Healthcare providers are increasingly recommending montelukast as an adjunct therapy alongside inhaled corticosteroids for better asthma management. The COVID-19 pandemic has also played a role in shifting attention toward respiratory health, increasing awareness and diagnosis rates for chronic respiratory conditions. Furthermore, patient preference for non-invasive, oral treatments over inhaled medications has bolstered the adoption of montelukast sodium as a first-line therapy in several regions.

What Are the Key Factors Driving Growth in the Montelukast Sodium Market?

The growth in the montelukast sodium market is driven by several factors, including the rising prevalence of respiratory diseases, expanding pharmaceutical innovations, and increasing awareness about allergic conditions. The demand for cost-effective and easily accessible asthma treatments has propelled the adoption of montelukast across developed and emerging markets. The expansion of generic drug manufacturers has also increased market penetration, making montelukast more affordable and widely available. Additionally, the growing use of combination therapies, where montelukast is paired with antihistamines or corticosteroids, is creating new opportunities for pharmaceutical companies. Government initiatives promoting asthma management programs and increased healthcare spending in emerging economies are further contributing to market growth. The shift toward personalized medicine and research into biomarkers for better treatment outcomes is also expected to enhance the future potential of montelukast sodium. As the global burden of respiratory diseases continues to rise, the montelukast sodium market is set for sustained expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Montelukast Sodium market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets Form, Oral Solutions); Application (Asthma Application, Allergic Rhinitis Application, Urticaria Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Aarti Pharmalabs Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories
  • Hetero Drugs Limited
  • Inke S.A.
  • Intas Pharmaceuticals Ltd.
  • Jai Radhe Sales
  • Kimia Biosciences Ltd.
  • LGM Pharma
  • Merck & Co., Inc.
  • Metrochem API Private Limited
  • Minakem (formerly Delmar Chemicals)
  • Morepen Laboratories Ltd.
  • Neuland Laboratories Ltd.
  • Sanofi S.A.
  • Seqens
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Montelukast Sodium - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Asthma and Allergic Rhinitis Drives Growing Demand for Montelukast Sodium
    • Rising Awareness of Non-steroidal Treatments for Asthma and Allergies Expands Market Opportunities for Montelukast Sodium
    • Strengthened Focus on Personalized Medicine Drives Adoption of Montelukast Sodium in Tailored Treatment Plans
    • Expanding Pediatric Use of Montelukast Sodium in Asthma Management Strengthens Market Outlook
    • Shift Toward Combination Therapy for Respiratory Disorders Generates Demand for Montelukast Sodium in Multi-drug Formulations
    • Ongoing Clinical Research and Trials Highlight the Benefits of Montelukast Sodium in Treating Multiple Respiratory Conditions
    • Regulatory Approvals for Generic Montelukast Sodium Drive Market Penetration and Reduce Treatment Costs
    • Growth in the Aging Population Accelerates Demand for Montelukast Sodium in Chronic Disease Management
    • Increasing Preference for Oral Medications Drives Montelukast Sodium Adoption in Asthma and Allergy Treatment Protocols
    • Global Initiatives to Improve Respiratory Disease Management Stimulate Demand for Effective Non-corticosteroid Therapies Like Montelukast Sodium
    • Technological Innovations in Drug Delivery Systems Enhance the Efficacy and Market Appeal of Montelukast Sodium
    • Rising Healthcare Expenditure and Investment in Respiratory Disease Treatments Strengthen Market Growth for Montelukast Sodium
    • Growing Use of Montelukast Sodium in Allergy Treatment and Chronic Sinusitis Expands Its Addressable Market Opportunity
    • Increased Focus on Long-term Management of Asthma Drives Sustainable Growth in Montelukast Sodium Usage
    • Expansion of Over-the-counter (OTC) Availability of Montelukast Sodium Formulations Accelerates Market Penetration
    • Increasing Incidence of Air Pollution and Allergies in Urban Populations Drives Growth for Montelukast Sodium
    • Enhanced Patient Compliance with Once-daily Dosing Regimens Strengthens the Adoption of Montelukast Sodium
    • Stronger Focus on Preventive Healthcare Measures Drives Proactive Use of Montelukast Sodium in At-risk Populations
    • Advancements in Combination Therapies that Integrate Montelukast Sodium Expand Treatment Options and Market Potential
    • Ongoing Evaluation of the Safety Profile of Montelukast Sodium Strengthens Its Position as a Frontline Treatment Option
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Montelukast Sodium Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Montelukast Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oral Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oral Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Oral Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Allergic Rhinitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Allergic Rhinitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Allergic Rhinitis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urticaria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urticaria Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Urticaria Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Montelukast Sodium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Montelukast Sodium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Montelukast Sodium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Montelukast Sodium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Montelukast Sodium by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Montelukast Sodium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Montelukast Sodium by Dosage Form - Tablets Form and Oral Solutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Montelukast Sodium by Dosage Form - Percentage Breakdown of Value Sales for Tablets Form and Oral Solutions for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Montelukast Sodium by Application - Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Montelukast Sodium by Application - Percentage Breakdown of Value Sales for Asthma Application, Allergic Rhinitis Application, Urticaria Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제